跳至主要内容
临床试验/IRCT20230627058596N1
IRCT20230627058596N1招募中3 期

Effect of Atorvastatin Usage on Oxidative stress-related Marker Superoxide dismutase and Angiogenesis Factors in the Saliva of Patients with Oral squamous cell carcinoma: A Randomized Clinical Trial

Karaj University of Medical Sciences0 个研究点目标入组 30 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
发起方
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
no limit 至 no limit(—)
性别
All

入选标准

  • Patients with oral squamous cell carcinoma
  • Lack of any other cancer except for oral squamous cell carcinoma
  • Not using any medication other than the ones prescribed by the surgeon
  • No drug interaction with atorvastatin if taken concurrently with another medication
  • Biopsy result of the patient indicates squamous cell carcinoma of the oral mucosa
  • Having similar histopathology grades
  • Ability to personally provide written informed consent or to understand and collaborate throughout the study

排除标准

  • Inability or unwillingness to comply with study requirements
  • Patients who were previously taking statins for any reason
  • Treatment approach for oral squamous cell carcinoma varies due to its unique challenges
  • Patients undergoing treatment with anti-HIV drugs
  • Having a history of other cancers
  • Smoker patients
  • Patients who are consumers of a specific medication
  • Patients with specific systemic diseases
  • Patients with a history of intolerance to statins
  • Patients with acute liver failure
  • Pregnant and lactating women
  • consumption of another drug that interacts with atorvastatin
  • consumption of Gemfibrozil medication
  • consumption of Clarithromycin medication
  • consumption of Cyclosporine medication
  • consumption of Itraconazole medication
  • consumption of Colchicine medication

研究者

发起方
Karaj University of Medical Sciences

相似试验